MedTrace Logo

Ciprofol Versus Propofol in Patients Undergoing Painless Hysteroscopy

NCT06413862 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 188

Last updated 2024-08-07

No results posted yet for this study

Summary

Ciprofol exhibits comparable efficacy to that of propofol, and is associated with less injection pain rate, fewer adverse events, higher patient satisfaction, and more stable hemodynamics when used for general anesthesia during the painless hysteroscopy.

Conditions

  • Painless Hysteroscopy

Interventions

DRUG

Ciprofol

The experimental group was slowly injected with ciprofol for 30 seconds (0.4mg/kg, Haisike Pharmaceutical Co., Ltd., Liaoning, China, batch number 20220911).

DRUG

Propofol

The control group was slowly injected with propofol for 30 seconds (2mg/kg, Guorui Pharmaceutical Co., Ltd., Sichuan, China, batch number 22102914).

Sponsors & Collaborators

  • Baoding First Central Hospital

    lead OTHER

Principal Investigators

  • Lei Zhu · the First Central Hospital of Baoding

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-10
Primary Completion
2024-09-09
Completion
2024-09-10

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06413862 on ClinicalTrials.gov